Eliem Therapeutics

ELYM58

$5.16arrow_drop_up1.17%$0.06

ELYM58

$5.16

arrow_drop_up1.17%$0.06

Performance History

Key Stats
Open	$5.07
Prev. Close	$5.10
EPS	-2.22
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	4.94	5.23
52 Week Range	2.35	11.55

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.22

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Eliem Therapeutics (ELYM)

Eliem Therapeutics, Inc. (ELYM) is a pharmaceutical company that focuses on developing innovative therapies for various medical conditions. The company is dedicated to transforming the lives of patients by providing them with effective and safe treatment options. With a strong commitment to research and development, Eliem Therapeutics aims to bring novel drugs to the market that address significant unmet medical needs.

As of the most recent stock price history, ELYM has shown a steady performance. Investors can monitor the fluctuations in ELYM stock price to make informed decisions. The company's quote reflects the current trading price, enabling investors to track the market value of ELYM shares. Staying updated with ELYM stock news can provide insights into the company's latest developments, partnerships, and financial performance.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Redmond
Employees: 30
Exchange: NASDAQ

Keep an eye on Eliem Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Eliem Therapeutics's (ELYM) price per share?

The current price per share for Eliem Therapeutics (ELYM) is $5.16. The stock has seen a price change of $0.06 recently, indicating a 1.18% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Eliem Therapeutics (ELYM)?

For Eliem Therapeutics (ELYM), the 52-week high is $11.55, which is 123.84% from the current price. The 52-week low is $2.35, the current price is 119.57% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Eliem Therapeutics (ELYM) a growth stock?

Eliem Therapeutics (ELYM) has shown an average price growth of -1.93% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eliem Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Eliem Therapeutics (ELYM) stock price performance year to date (YTD)?

As of the latest data, Eliem Therapeutics (ELYM) has a year-to-date price change of 84.29%. Over the past month, the stock has experienced a price change of -35.18%. Over the last three months, the change has been -24.67%. Over the past six months, the figure is 16.48%.

help

Is Eliem Therapeutics (ELYM) a profitable company?

Eliem Therapeutics (ELYM) has a net income of -$35.12M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$21.47M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Eliem Therapeutics (ELYM)?

Eliem Therapeutics (ELYM) has a market capitalization of $342.68M. The average daily trading volume is 1.33M, indicating the stock's liquidity and investor engagement.